Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-6-9
pubmed:abstractText
Beta-Lapachone a novel topoisomerase inhibitor, has been found to induce apoptosis in various human cancer cells. In this study we report that a dramatic elevation of hydrogen peroxide (H2O2) in human leukemia HL-60 cells following 1 microM beta-lapachone treatment and that this increase was effectively inhibited by treatment with antioxidant N-acetyl-L-cysteine (NAC), ascorbic acid, alpha-tocopherol. NAC strongly prevented beta-lapachone-induced apoptotic characteristics such as DNA fragmentation and apoptotic morphology. However, treatment of HL-60 cells with another topoisomerase inhibitor camptothecin (CPT) did not induce H2O2 production as compared to untreated cells. NAC also failed to block CPT-induced apoptosis. Correlated with these findings, we found that cancer cell lines K562, MCF-7, and SW620, contained high level of intracellular glutathione (GSH), were not elevated in H2O2 and were resistant to apoptosis after treatment with beta-lapachone. In contrast, cancer cell lines such as, HL-60, U937, and Molt-4 which have lower level of GSH, were readily increased of H2O2 and were sensitive to this drug. Furthermore, ectopic overexpression of Bcl-2 in HL-60 cells also attenuated beta-lapachone-induced H2O2 and conferred resistance to beta-lapachone-induced cell death. Beta-Lapachone at the concentration as low as 0.25 microM effectively induced HL-60 cells to undergo monocytic differentiation, as evidenced by CD14 antigenicity and alpha-naphthyl acetate esterase activity. Again, the beta-lapachone-induced monocytic differentiation was suppressed by NAC. These results suggest that intracellular H2O2 generation plays a crucial role in beta-lapachone-induced cell death and differentiation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0891-5849
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
660-70
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:9559879-Acetylcysteine, pubmed-meshheading:9559879-Antioxidants, pubmed-meshheading:9559879-Apoptosis, pubmed-meshheading:9559879-Ascorbic Acid, pubmed-meshheading:9559879-Cell Differentiation, pubmed-meshheading:9559879-DNA Fragmentation, pubmed-meshheading:9559879-Drug Resistance, pubmed-meshheading:9559879-Enzyme Inhibitors, pubmed-meshheading:9559879-Glutathione, pubmed-meshheading:9559879-Humans, pubmed-meshheading:9559879-Hydrogen Peroxide, pubmed-meshheading:9559879-Leukemia, Promyelocytic, Acute, pubmed-meshheading:9559879-Monocytes, pubmed-meshheading:9559879-Naphthoquinones, pubmed-meshheading:9559879-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:9559879-Topoisomerase I Inhibitors, pubmed-meshheading:9559879-Tumor Cells, Cultured, pubmed-meshheading:9559879-Vitamin E
pubmed:year
1998
pubmed:articleTitle
Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells.
pubmed:affiliation
Institute of Anatomy, School of Life Sciences, National Yang-Ming University, Taiwan.
pubmed:publicationType
Journal Article